FDA Expands Bivalent COVID-19 Booster Eligibility for Vulnerable Populations
New Guidance for High-Risk Groups The U.S. Food and Drug Administration (FDA) announced on Tuesday an amendment to the emergency use authorizations for Pfizer-BioNTech and Moderna bivalent COVID-19 vaccines. This regulatory shift permits adults aged 65 and older, as well as specific immunocompromised individuals, to receive an additional dose of the updated booster, providing an…